The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ERCC1, p16, and ki-67 immunohistochemichal expression as predictive and prognostic markers in head and neck squamous cell carcinoma treated with platin-based induction chemotherapy: Staining with the two anti-ERCC1 antibodies (8F1 and FL-297) was compared.
Helene Roussel
No relevant relationships to disclose
Martin Housset
No relevant relationships to disclose
Helene Tournat
No relevant relationships to disclose
Patrice Ravel
No relevant relationships to disclose
Stephane Hans
No relevant relationships to disclose
Patrick Bruneval
No relevant relationships to disclose
Cecile Badoual
No relevant relationships to disclose